• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Variable Transfusion Practices for Bleeding ICU Patients Globally

January 19, 2022

Approximately 40-50% of patients in the intensive care unit (ICU) receive blood transfusions.  Many studies have focused on bleeding in trauma patients who are usually healthy.  Patients in the ICU, however, more often have multiple comorbidities and may require a more nuanced transfusion approach.  To better understand transfusion practices in massively bleeding and non-massively bleeding patients in the ICU, experts in the transfusion medicine community from North America and Europe compiled 50 questions and distributed an online questionnaire to physicians working in adult ICUs globally.  A total of 401 qualified physicians completed the survey from 64 countries—mainly high-income countries (72%).  Over half of the respondents reported a massive transfusion protocol at their institution (52%).  Furthermore, 46% reported using a fixed blood product ratio for massive transfusions; 1:1:1 (RBC: plasma: platelets) was the most common ratio (33%).  In non-massively bleeding patients, respondents reported different hemoglobin (Hb) thresholds for RBC transfusions depending on the patient subpopulation.  For the general ICU population, respondents reported using a median Hb threshold of 7.0 g/dL (interquartile range of 7.0 to 7.3 g/dL), but this threshold was higher for cardiothoracic surgery patients (median 8 g/dL, interquartile range 7.9 to 9 g/dL).  This survey highlights the need for more research and variability in transfusion practices in the general population of bleeding patients.

Reference:

  1. De Bruin S, Eggermont E, van Bruggen R, de Korte D, et al.  Transfusion practice in the bleeding critically ill:  an international online survey—the TRACE-2 survey.  Transfusion 2022; 1-12.

Filed Under

  • News
  • RBC Transfusion

Recommended

  • CRISPR-Cas9 Gene Editing and Lentiviral Gene Therapy Hold Promise to Treat Transfusion Dependent β-Globin Hemoglobinopathies

  • RHD Genotyping in Transfusion Practice Could Identify Novel RHD Alleles and Conserve D-negative Blood

  • Better Screening Methods for Zika Virus Are Needed to Protect the Blood Supply

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Blood Donation Teams—a Novel Strategy to Support Novice Donors

  • Plasma Exchange to Reduce Biological Age

  • New Guidelines for Platelet Transfusion Recommend Restrictive Strategies

  • Directed Blood Donations Should be Limited

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley